Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash

NCT03471364 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm

Interventions

DRUG: Ketoconazole
OTHER: Laboratory Biomarker Analysis
OTHER: Placebo Administration
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

Mayo Clinic

Collaborators

[object Object]